[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
NIMAR – The list was updated 21.12.2022

NIMAR – The list was updated 21.12.2022

by Ryan Watts | Dec 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

NIMAR – The list was updated 21.12.2022

NIMAR – The list is getting longer…

by Sally Finlayson | Nov 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

Are you decommissioning products with the correct status?

Are you decommissioning products with the correct status?

by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP

The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

he UK MAs currently cover the whole of the “UK” so the UK MAs include Northern Ireland Supply…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

Lets start with the definition GB is now only…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in Northern Ireland (NI) need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

For Northern Irish Pharmacies FMD requirements have not changed and they must continue to verify and decommission their “2D” barcoded packs…

« Older Entries

Recent Posts

  • GDP certificates do not expire
  • Parallel Trade – A reminder
  • Journalists – Be Careful What You Write About Medicines

Upcoming Courses

  • Licence Holder Training on 10 June 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 17 June 2025
  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP Audit Online Training on 9 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025

MHRA Alerts & Recalls

Class 4 Medicines Notification, Zentiva Pharma UK Limited, Various Products, EL(25)A/24
2 June 2025
Philips Respironics BiPAP A series ventilators: alarm malfunction and risk of therapy interruptions in ventilators not intended for life-support, DSI/2024/006
23 May 2025
Class 2 Medicines Recall: Mercaptopurine 50mg Tablets, Aspen Pharma Trading Limited, EL (25)A/23
22 May 2025
Field Safety Notices: 12 to 16 May 2025
20 May 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow